COR 8-K
Cencora, Inc. (COR)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
Commission File Number:
| (State or other jurisdiction of | (I.R.S. Employer | |||
| incorporation or organization) | Identification No.) | |||
| (Address of principal executive offices) | (Zip Code) | |||
(
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report.)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of exchange on which registered |
| New
York Stock Exchange ( |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
| Item 5.07. | Submission of Matters to a Vote of Security Holders. |
| (a) | Cencora, Inc. (the “Company”) held its 2025 Annual Meeting of Shareholders (the “Annual Meeting”) on March 6, 2025. |
| (b) | Each of the three items listed below was submitted to a vote of the Company's shareholders at the Annual Meeting and is described in more detail in the definitive proxy statement filed by the Company with the Securities and Exchange Commission on January 23, 2025 (the “Proxy Statement”). The final voting results are set forth below: |
Item 1 - Election of Directors.
Each of the individuals listed below was elected by the Company’s shareholders.
| Nominees | For | Against | Abstentions | Broker Non-Votes | |||||||||
| Ornella Barra | 168,413,582 | 762,532 | 166,952 | 9,542,398 | |||||||||
| Werner Baumann | 165,837,072 | 3,354,227 | 151,767 | 9,542,398 | |||||||||
| Frank K. Clyburn | 167,730,172 | 1,458,056 | 154,838 | 9,542,398 | |||||||||
| Steven H. Collis | 165,458,442 | 3,759,064 | 125,560 | 9,542,398 | |||||||||
| D. Mark Durcan | 168,590,464 | 597,571 | 155,031 | 9,542,398 | |||||||||
| Lon R. Greenberg | 153,366,924 | 15,673,799 | 302,343 | 9,542,398 | |||||||||
| Lorence H. Kim, M.D. | 167,048,677 | 2,132,892 | 161,497 | 9,542,398 | |||||||||
| Robert P. Mauch | 167,590,712 | 1,597,295 | 155,059 | 9,542,398 | |||||||||
| Redonda G. Miller, M.D. | 164,014,442 | 5,165,281 | 163,343 | 9,542,398 | |||||||||
| Dennis M. Nally | 166,267,786 | 2,918,693 | 156,587 | 9,542,398 | |||||||||
| Lauren M. Tyler | 161,743,928 | 7,426,800 | 172,338 | 9,542,398 | |||||||||
Item 2 - Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers.
The Company’s shareholders approved this item. The voting results were as follows:
| For | Against | Abstentions | Broker Non-Votes | ||||||||
| 156,885,713 | 12,269,867 | 187,486 | 9,542,398 | ||||||||
Item 3 - Ratification of Appointment of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm for Fiscal Year 2025.
The Company’s shareholders approved this item. The voting results were as follows:
| For | Against | Abstentions | Broker Non-Votes | ||||
| 166,297,099 | 12,410,706 | 177,659 | N/A |
No item other than the three items addressed above and described in the Proxy Statement was submitted at the Annual Meeting for shareholder action.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Cencora, Inc. | |||
| March 10, 2025 | By: | /s/ Elizabeth S. Campbell | |
| Name: | Elizabeth S. Campbell | ||
| Title: | Executive Vice President and Chief Legal Officer | ||